⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTL News
Artelo Biosciences, Inc. Common Stock
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients
globenewswire.com
ARTL
Form 8-K
sec.gov
ARTL
Form 8-K
sec.gov
ARTL
Artelo Biosciences Announces Reverse Stock Split
globenewswire.com
ARTL
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
globenewswire.com
ARTL
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
globenewswire.com
ARTL
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical
globenewswire.com
ARTL
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results
globenewswire.com
ARTL
Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer
globenewswire.com
ARTL
Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer
globenewswire.com
ARTL